Pharmacy Practice: Comparison Between the Developing Countries

This chapter compares the practice of community pharmacy practice, hospital pharmacy practice, and pharmacy practice issues in high-income, middle-income, and low-income developing countries. It delves into various aspects of community pharmacy practice, including their history, licensure requirements, characteristics, workforce issues, salaries, dispensing practice, health screening services, vaccination services, compounding services, nutrition care and services, smoking cessation programs and services, antimicrobial stewardship, patient care practice, patient safety practice, continuous professional development (CPD), interprofessional and intraprofessional practice, pharmacist prescribing, online pharmacies and telepharmacy services, community pharmacy services in rural areas, cost considerations, technology in practice, and finally, achievements, challenges, and recommendations. Pharmacy practice, a fundamental component of healthcare systems worldwide, is influenced by the economic status and resources available in a given country. This chapter compares pharmacy practice issues in high-income, middle-income, and low-income developing countries across various dimensions, including pharmaceutical industries, pharmaceutical marketing, regulatory affairs, drug information and poison centers, medication safety programs, pharmacy practice during disasters, and pharmacist care services. In high-income countries, well-established pharmaceutical industries and stringent regulations foster innovation and product quality, while complex pharmaceutical marketing practices and healthcare disparities pose challenges. Middle-income countries exhibit diverse pharmaceutical landscapes, with some nations excelling in manufacturing and regulatory capacity, while others face issues related to marketing regulation. Low-income countries, often reliant on imports, struggle with pharmaceutical infrastructure and access to essential medicines. Pharmacy practice in these countries is further influenced by drug information and poison centers, medication safety initiatives, and disaster response capabilities. High-income countries typically have advanced drug information and poison centers and sophisticated medication safety programs, whereas low-income countries may lack these critical resources. Disaster response mechanisms also vary, with high-income countries showcasing robust systems and low-income countries often grappling with challenges. Additionally, pharmacist care services, including medication therapy management and chronic disease management, differ significantly. High-income countries have integrated pharmacist care into healthcare teams, whereas middle-income countries are in the process of recognition and integration. Low-income countries often struggle with limited pharmacist involvement in patient care. While each category presents achievements, challenges, and recommendations tailored to the specific economic context, several overarching recommendations emerge. High-income countries must address healthcare disparities, pharmaceutical pricing, and overreliance on certain medications. Middle-income countries should invest in research and regulatory capacity, while low-income countries need international support in building pharmaceutical infrastructure, ensuring access to medicines, and enhancing healthcare resilience during disasters. Collaboration and international assistance are essential in advancing pharmacy practice globally and addressing complex healthcare challenges that transcend economic boundaries. Ultimately, this chapter aims to provide insights into the multifaceted field of pharmacy practice, fostering discussions on strategies to enhance healthcare delivery and improve patient outcomes in diverse economic settings.